Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angde Biotech Pharmaceutical is a China-based biopharmaceutical company specializing in the development and manufacturing of recombinant protein drugs and high-end generic medications. The company is best known for its expertise in anticoagulant therapies, particularly its production of recombinant hirudin, a potent thrombin inhibitor used for treating thrombotic diseases. Angde Biotech operates integrated research, development, and GMP-certified manufacturing facilities to support its pipeline of biologics and small molecules. Its portfolio primarily targets cardiovascular health, metabolic disorders, and hematology, positioning the firm as a significant player in the Chinese domestic biopharma landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angde Biotech Pharmaceutical.